University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health

Conditions: Preterm Birth
Preeclampsia

First Posted Date: 2013-06-28

Last Posted Date: 2016-05-25

Lead Sponsor: University of Oxford

Target Recruit Count: 300

Registration Number: NCT01888770

Locations: 🇬🇧
Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S

Phase 1

Completed

Conditions: Plasmodium Falciparum Malaria

Interventions: Biological: RTS,S/AS01B
Biological: ChAd63 ME-TRAP
Biological: MVA ME-TRAP

First Posted Date: 2013-06-21

Last Posted Date: 2014-10-01

Lead Sponsor: University of Oxford

Target Recruit Count: 48

Registration Number: NCT01883609

Locations: 🇬🇧
Wellcome Trust CRF, Southampton General Hospital, University of Southampton, Southampton, Hampshire, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧
Infection and Immunity Section, Sir Alexander Fleming Building, Imperial College of Science, Technology and Medicine, London, United Kingdom

and more 1 locations

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

Phase 1

Completed

Conditions: Tuberculosis (TB)

Interventions: Biological: MVA85A-IMX313
Biological: MVA85A

First Posted Date: 2013-06-17

Last Posted Date: 2014-12-16

Lead Sponsor: University of Oxford

Target Recruit Count: 30

Registration Number: NCT01879163

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧
Wellcome Trust Clinical Research Facility, Birmingham, United Kingdom

Targeted Screening of At-Risk Adults for Acute HIV-1 Infection

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: intense follow up

First Posted Date: 2013-06-12

Last Posted Date: 2014-08-04

Lead Sponsor: University of Oxford

Target Recruit Count: 522

Registration Number: NCT01876199

Locations: 🇰🇪
KEMRI Mtwapa, Kilifi, Kenya

Visual and Functional Assessment in Low Vision Patients

Completed

Conditions: Optic Nerve Pathology
Inherited Retinal Dystrophies
Retinitis Pigmentosa
Age-related Macular Degeneration

First Posted Date: 2013-06-12

Last Posted Date: 2019-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT01876147

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

Targeted Chemo-elimination (TCE) of Malaria

Not Applicable

Completed

Conditions: Plasmodium Falciparum Malaria

Interventions: Drug: malaria elimination using DP and low-dose primaquine

First Posted Date: 2013-06-07

Last Posted Date: 2020-08-28

Lead Sponsor: University of Oxford

Target Recruit Count: 8000

Registration Number: NCT01872702

Locations: 🇻🇳
Oxford University Clinical Research Unit - Vietnam, Ho Chi Minh city, Vietnam
🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
🇰🇭
Pailin, Pailin, Cambodia

and more 2 locations

Binocular Vision in Monocular Pseudophakia

Not Applicable

Terminated

Conditions: Cataract

Interventions: Procedure: Cataract surgery

First Posted Date: 2013-06-07

Last Posted Date: 2019-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT01872000

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom
🇬🇧
Stoke Mandeville Hospital, Aylesbury, United Kingdom

Iron Status and Hypoxic Pulmonary Vascular Responses

Not Applicable

Completed

Conditions: Pulmonary Arterial Hypertension
Lung Hypoxia
Iron Deficiency

Interventions: Drug: Intravenous administration of ferric carboxymaltose
Other: Subacute hypoxic exposures

First Posted Date: 2013-05-06

Last Posted Date: 2016-05-06

Lead Sponsor: University of Oxford

Target Recruit Count: 31

Registration Number: NCT01847352

Locations: 🇬🇧
University of Oxford Department of Physiology, Anatomy and Genetics, Oxford, Oxfordshire, United Kingdom

TES for the Treatment of RP

Not Applicable

Completed

Conditions: Retinitis Pigmentosa

Interventions: Device: Transcorneal electrical stimulation

First Posted Date: 2013-05-06

Last Posted Date: 2018-11-13

Lead Sponsor: University of Oxford

Target Recruit Count: 14

Registration Number: NCT01847365

Locations: 🇬🇧
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Biological: ChAdOx1 85A
Biological: MVA85A

First Posted Date: 2013-04-11

Last Posted Date: 2016-05-12

Lead Sponsor: University of Oxford

Target Recruit Count: 42

Registration Number: NCT01829490

Locations: 🇬🇧
The NIHR/ Wellcome Trust Clinical Research Facility, University of Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine , University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy